2018 annual financial data
Theravance Biopharma 2018 Operating margin
Direct answer
Operating margin was -395.48%.
Operating income was -238,751,000 USD and net income was -215,524,000 USD.
Operating cash flow was -112,867,000 USD.
Get free Theravance Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 60,370,000 USD
- Operating income
- -238,751,000 USD
- Net income
- -215,524,000 USD
- Operating cash flow
- -112,867,000 USD